Category Archives: Gesundheit/Medizin

Gesundheit/Medizin

Glycomics/Glycobiology Market: market size and market forecast by 2021

According to the new market research report Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User – Global Forecast to 2021, published by MarketsandMarkets™, The global glycomics/glycobiology market is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3%. The market is segmented based on product, application, end user, and region.

Don’t miss out on business opportunities in Glycomics/Glycobiology Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2NAHFGI

Early buyers will receive 10% customization on reports.

The global glycomics/glycobiology market is expected to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. Glycomics is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes. This study is used in diagnostics, drug discovery research, immunology, oncology, and various other applications. Glycomics products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Market Dynamics

Drivers

  • Increasing funding for proteomics & glycomics research and growing R&D expenditure
  • Growth of the proteomics market
  • Technological advancements in glycomics instrumentation

Restraints

  • High degree of consolidation acts as an entry barrier for new entrants
  • Stringent regulatory frameworks and time-consuming approval processes

Opportunities

  • Increased use of personalized medicine
  • Biomarkers identification
  • Developing countries and emerging markets

Challenges

  • High cost of tools and instruments and their maintenance

Increasing funding for proteomics & glycomics research and growing R&D expenditure drives the global glycomics market

The growing demand for remedial treatments for life-threatening diseases, such as cancer, has driven the pace of pharmaceutical and biotechnological R&D as well as overall investments made in this sector. Both glycomics (being the study of glycans) and proteomics (being the study of proteins, and holding a prominent place in glycome R&D) are research-driven sectors. Moreover, glycomic biomarkers are finding significant applications in drug development and diagnostics for such diseases. As a result, the growing availability of funding for these two sectors is expected to aid the growth of the glycomics market, in the coming years.

Browse and in-depth TOC on “Glycomics/Glycobiology Market

91 – Tables

32 – Figures

158 – Pages

 

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/glycobiology-market-132685525.html

The key players in the glycomics/glycobiology market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

Request for Free Sample Report @ http://bit.ly/2QIC7M2

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/glycobiology-market.asp

Visit Our Website: https://www.marketsandmarkets.com

Gesundheit/Medizin

Laboratory Freezers Market worth $3.76 Billion by 2021

According to the new market research report Laboratory Freezers Market by Product (Cryopreservation, Plasma Freezer, Explosion-Proof Freezer, Enzyme Freezer, Ultra-Low Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Chromatography Refrigerator) & by End User – Global Forecast to 2021, published by MarketsandMarkets™,The Global Laboratory Freezers Market is projected to reach USD 3.76 Billion by 2021 at a CAGR of 4.6% from 2016 to 2021.

Don’t miss out on business opportunities in Laboratory Freezers Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2QLfPJS

Early buyers will receive 10% customization on reports.

The increasing number of organs transplant procedures, growing demand for blood and blood components, and technological advancements in freezers and refrigerators are the key factors driving the growth of the laboratory freezers market. However, factors such as increasing use of refurbished equipment and intense pricing pressure on manufacturers are restraining the growth of this market.

In this report, the laboratory freezers market is segmented by product type, end user, and region. Based on product type, the market is segmented into freezers, refrigerators, and cryopreservation systems. The freezers segment accounted for the largest share in 2015, primarily due to the high demand for freezers for the storage of laboratory samples as a result of the growing number of laboratory tests globally, coupled with the growth in demand for blood and plasma for transfusion and plasma fractionation procedures. However, the cryopreservation systems segment is estimated to register a higher growth due to the growing use of cryopreservation techniques and equipment for the storage of cell lines.

Browse and in-depth TOC on “Laboratory Freezers Market

154 – Tables

33 – Figures

183 – Pages

 

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/laboratory-freezer-market-196600540.html

Thermo Fisher Scientific Inc. is one of the top players in the market. The company operates in more than 180 countries across North America, Europe, Asia, and Latin America. It offers HCS instruments and software among other products. The company focuses on product launches as its key business strategy. In May 2016, the company launched the Invitrogen Evos FL Auto 2 Imaging System to provide rapid capture and analysis of higher-quality images in live-cell imaging experiments. In addition, in January 2016, Thermo Fisher Scientific launched the Cell Insight CX7 high-content analysis platform. This strengthened the company’s hold in the HCS market.

The key strategies adopted by major players in the global high-content screening market are agreements, partnerships & collaborations, acquisitions, product launches, and geographic expansions. In this competitive market, global players aim to maintain their market position through continuous investments in R&D with a focus on developing innovative solutions or enhancing their existing solutions.

Request for Free Sample Report @ http://bit.ly/2OTrWqR

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com

Gesundheit/Medizin

Tissue Diagnostics Market Is Expected To Generate Huge Profits by 2016-2026

Tissue is a group or layer of cells which perform a particular function and contain necessary biological information. Tissue samples are used for cancer diagnosis and analysis, where it captures the biological context of the disease. It conforms the presence of cancer by examining the tissue sample under microscope by a trained physician called a pathologist. Histopathology is a study of disease in a tissue which can be done by small biopsies, fine needle aspiration cytology and open biopsy or surgery. The three major types of tissue diagnosis, Hematoxylin and Eosin (H&E), Immunohistochemistry (IHC) and In situ hybridization. H&E stains work well with a variety of fixatives and displays a broad range of cytoplasmic, nuclear, and extracellular matrix features. Immunohistochemistry (IHC) is one of the most useful new diagnostic markers where proteins are stained using antibodies. And In situ hybridization identifies specific nucleotide sequences in the cells and tissues.

Tissue Diagnostics Market: Drivers & Restraints        

Tissue Diagnosis technique is said to be one of the gold standards set in cancer diagnosis and is the crucial driver in the market. Tissue based diagnosis technique helps to determine the cause and effect of the disease in a patient. Due to unhealthy lifestyles of population the rate of cancer incidences is growing each year and so is driving the market for tissue based diagnosis. Cancer diagnosis at early stages and treatment will lead to better chances of survival and the market for diagnostics will show significant growth by forcing labs to increase efficiency in the diagnosis process to maximize health securities in patients. In developed countries there is enough health awareness as compared to the developing countries for which various factors are responsible as economic factors, low health literacy and increasing regulatory requirements hamper the market opportunities and growth.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-406

Tissue Diagnostics Market: Segmentation

Tissue Diagnostic market is classified on the basis of product, technology, disease and end users.

Based on the product type the global tissue diagnostic market is segmented into following:

  • Instruments
    • Microscope
    • Non-contact Handheld IR Thermometer
    • Haemocytometer
    • NMR Tube
    • Others
  • Consumables
    • Reagent Kits
    • Others

Based on the application the global tissue diagnostic market is segmented into following:

  • Hematoxylin and Eosin (H&E)
  • Immunohistochemistry (IHC)
  • In Situ Hybridization

Based on the disease the global tissue diagnostic market is segmented into following:

  • Lung Cancer
  • Lymphoma
  • Pancreatic Cancer
  • Breast Cancer
  • Others

Based on the end user the global tissue diagnostic market is segmented into following:

  • Hospitals
  • Diagnostic laboratories
  • Research Organizations
  • Contract Research Organizations
  • Biotechnology Companies

Tissue Diagnostics Market: Overview

Tissue Diagnostic market is a growing market due to increasing cancer awareness campaigns, advance research technology, improving healthcare infrastructure is leading to better market opportunities in tissue diagnostics. Personalized healthcare and companion diagnostics, IVD Development and Digital Pathology and Integrated Diagnostics are the major concerns of the tissue diagnostic market which are giving positive results and address health issues. Significant research is being carried out giving rise to the emerging technologies to meet the medical needs in the tissue diagnostic market. Tissue diagnostic market is also segmented into pre-analytical and advance stains on the basis of the examination time.

Tissue Diagnostic Market: Region-wise Outlook

Depending on geographic regions, global radiofrequency ablation system market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. The global tissue market is segmented into seven regions amongst which North America is the largest tissue diagnostic market due to prevalence of cancer and health literacy supported by modern diagnostic techniques available. Europe is observed to be the second largest regional segment in the global tissue diagnostics market.

Tissue Diagnostic Market: Key Players

The key market players in global tissue diagnostic market are F. Hoffmann-La Roche AG, Sigma-Aldrich Co. LLC, Abbott Laboratories, Agilent Technologies, BioGenex, Danaher Corporation, Cell Signaling Technology and Ventana Medical Systems.

Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-406

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Aktuelle Nachrichten Gesundheit/Medizin Pressemitteilungen

Medical Animation Market is Projected to Boost $514 Million by 2024: Grand View Research Inc.

San Francisco,17 October 2018: The global medical animation market is expected to reach a value of USD 514.0 million by 2024, according to a new report by Grand View Research. Key factors driving the market growth include the higher adoption of medical animation marketing by medical devices manufacturers and pharmaceutical products. It helps in explaining product features and communicating associated information with end users.

The information represented by animation is more appealing and easy to transmit. These aforementioned benefits are expected to boost the usage rate in near future. In addition, the paradigm shift, in healthcare information technology, such as digitalization, is anticipated to contribute towards the market growth in the next few years. The medical animation market has gained momentum after the introduction of cloud-based platforms and 3D printing technology in healthcare.

Furthermore, the introduction of technologically advanced software for image analysis, such as Medical Image Processing, Analysis, and Visualization can be attributed to the market growth. This application enables researcher from remote sites share valuable information and analyze the research data to detect, monitor, and treat medical disorders.  Medical animation is a versatile tool for communicating complex scientific procedures in an interactive manner and used in a variety of business aspects such as marketing, web presentations, social media, tradeshows and advertising. Increasing adoption of this technology is expected to serve as a potential growth driver in the future.

The increasing investment by private and public sector, growing geriatric population coupled with increasing demand for computer-aided diagnostics, and incidence of chronic diseases are major factors fueling the increasing usage rates of this technology. In addition, this technology found application in various sectors, for instance; it helps healthcare professionals explain human body metabolism to patients, which helps in reducing patient’s anxiety level and educates them about various disease condition.

Access Research Report of Medical Animation Market @ www.grandviewresearch.com/industry-analysis/medical-animation-market

Further Key Findings from the Study Suggest:

  • Flash animation is expected to be one of the most lucrative segment in near future due to increasing demand for patient engagement by healthcare professionals. On the other hand, 3D animation found application in clinical research studies, improving patient education, and simplifying complex procedures in bioscience studies by representing them into an animated form
  • Growing demand for technologically advanced medical animation solutions is expected to contribute towards the growth of 3D animation during the forecast period
  • In 2015, the drug mechanism of action segment accounted for the largest revenue share. The use of animation for explaining drug interactions and metabolic studies in new drug development are key contributing factors for this segment growth. This technology is used in animating preproduction, full production and post production process of drug molecules
  • However, the patient education segment is expected to emerge as the fastest growing segment as awareness levels amongst patients, introduction of user-friendly apps and concerns related to health information are increasing. For instance, introduction of 3D medical application such as complete anatomy in November 2015 by 3D4 medical used for anatomical studies
  • Currently, oncology segment dominates the market and is expected to be the fastest growing therapeutic area using this technology. Increasing incidence of cancer worldwide is a key contributing factor for growing demand of medical animation studies to explain disease mechanisms to patients
  • For instance, XVIVO, showcased animation software at the American Society of Clinical Oncology (ASCO) and also helped in the depiction of mechanism of action of Bavituximab, an investigative drug, believed to strengthen the immunity system in cancerous environment
  • Other end users of this market are life science companies, medical device manufactures, government authorities, forensic department, medico-legal firms, and insurance provider companies. This segment is expected to grow at fastest CAGR due to wide usage of 3D bioprinting and biosimulation studies in these fields
  • For example, in forensic studies, a medical animation is used to elaborate crime scene and medico-legal firms use 3D animation to explain pain management procedures, surgical techniques, and presenting anatomical studies. There are various surgical and clinical audiovisual animation studies available online
  • Asia Pacific is expected to be the fastest growing region during the forecast period. The growing geriatric population, increase in the chronic diseases, and ongoing development in healthcare sector is the factors anticipated to provide future growth platform for this industry in the next 7 years
  • In addition, rising outsourcing activities in this region due to availability and low cost of labor are anticipated to propel segment growth over the forecast period. For example, in India, the cost of medical animation services is 20% to 25% lower than the U.S. and Europe
  • The medical animation market is experiencing high competition as there are many small and big organization that offer these services. Introduction of low-cost software solutions for medical simulation is expected to boost the competition and is also expected to benefit several end users over the forecast period
  • Companies are involved in adopting sustainable strategies to gain competitive edges such as new product launch, product up gradation and collaborative agreements. For example, In April 2016, Fusion medical animation launched biotech brand services aimed at designing and developing innovative visuals for better understanding of complex products The aforementioned factors keeps the market rivalry at higher level

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the medical animation market by type, application, therapeutic area, end-use and region:

Medical Animation Market Type Outlook (Market revenue in USD Million, 2013 – 2024)

  • 3D Animation
  • 2D Animation
  • 4D Animation
  • Flash Animation

Medical Animation Market Application Outlook (Market Revenue in USD Million, 2013 – 2024)

  • Drug MoA
  • Patient Education
  • Surgical Training & Planning
  • Cellular & Molecular Studies
  • Others

Medical Animation Stationary Therapeutic Area Outlook (Market Revenue in USD Million, 2013 – 2024)

  • Oncology
  • Cardiology
  • Plastic Surgery
  • Dental
  • Others

Medical animation Market End-use Outlook (Market Revenue in USD Million, 2013 – 2024)

  • Hospitals
  • Life sciences
  • Academic institute
  • Medical device manufactures
  • Others

Medical Animation Market Regional Outlook (Market Revenue in USD Million, 2013 – 2024)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Access Press Release of Medical Animation Market@ www.grandviewresearch.com/press-release/global-medical-animation-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Gesundheit/Medizin

Tissue Diagnostics Market to Witness Steady Growth During the Forecast Period 2016-2026

Tissue is a group or layer of cells which perform a particular function and contain necessary biological information. Tissue samples are used for cancer diagnosis and analysis, where it captures the biological context of the disease. It conforms the presence of cancer by examining the tissue sample under microscope by a trained physician called a pathologist. Histopathology is a study of disease in a tissue which can be done by small biopsies, fine needle aspiration cytology and open biopsy or surgery. The three major types of tissue diagnosis, Hematoxylin and Eosin (H&E), Immunohistochemistry (IHC) and In situ hybridization. H&E stains work well with a variety of fixatives and displays a broad range of cytoplasmic, nuclear, and extracellular matrix features. Immunohistochemistry (IHC) is one of the most useful new diagnostic markers where proteins are stained using antibodies. And In situ hybridization identifies specific nucleotide sequences in the cells and tissues.

Tissue Diagnostics Market: Drivers & Restraints        

Tissue Diagnosis technique is said to be one of the gold standards set in cancer diagnosis and is the crucial driver in the market. Tissue based diagnosis technique helps to determine the cause and effect of the disease in a patient. Due to unhealthy lifestyles of population the rate of cancer incidences is growing each year and so is driving the market for tissue based diagnosis. Cancer diagnosis at early stages and treatment will lead to better chances of survival and the market for diagnostics will show significant growth by forcing labs to increase efficiency in the diagnosis process to maximize health securities in patients. In developed countries there is enough health awareness as compared to the developing countries for which various factors are responsible as economic factors, low health literacy and increasing regulatory requirements hamper the market opportunities and growth.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-406

Tissue Diagnostics Market: Segmentation

Tissue Diagnostic market is classified on the basis of product, technology, disease and end users.

Based on the product type the global tissue diagnostic market is segmented into following:

  • Instruments
    • Microscope
    • Non-contact Handheld IR Thermometer
    • Haemocytometer
    • NMR Tube
    • Others
  • Consumables
    • Reagent Kits
    • Others

Based on the application the global tissue diagnostic market is segmented into following:

  • Hematoxylin and Eosin (H&E)
  • Immunohistochemistry (IHC)
  • In Situ Hybridization

Based on the disease the global tissue diagnostic market is segmented into following:

  • Lung Cancer
  • Lymphoma
  • Pancreatic Cancer
  • Breast Cancer
  • Others

Based on the end user the global tissue diagnostic market is segmented into following:

  • Hospitals
  • Diagnostic laboratories
  • Research Organizations
  • Contract Research Organizations
  • Biotechnology Companies

Tissue Diagnostics Market: Overview

Tissue Diagnostic market is a growing market due to increasing cancer awareness campaigns, advance research technology, improving healthcare infrastructure is leading to better market opportunities in tissue diagnostics. Personalized healthcare and companion diagnostics, IVD Development and Digital Pathology and Integrated Diagnostics are the major concerns of the tissue diagnostic market which are giving positive results and address health issues. Significant research is being carried out giving rise to the emerging technologies to meet the medical needs in the tissue diagnostic market. Tissue diagnostic market is also segmented into pre-analytical and advance stains on the basis of the examination time.

Tissue Diagnostic Market: Region-wise Outlook

Depending on geographic regions, global radiofrequency ablation system market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. The global tissue market is segmented into seven regions amongst which North America is the largest tissue diagnostic market due to prevalence of cancer and health literacy supported by modern diagnostic techniques available. Europe is observed to be the second largest regional segment in the global tissue diagnostics market.

Tissue Diagnostic Market: Key Players

The key market players in global tissue diagnostic market are F. Hoffmann-La Roche AG, Sigma-Aldrich Co. LLC, Abbott Laboratories, Agilent Technologies, BioGenex, Danaher Corporation, Cell Signaling Technology and Ventana Medical Systems.

Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-406

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Aktuelle Nachrichten Gesundheit/Medizin Pressemitteilungen

Controlled Release Drug Delivery Market is Expected to Expand at a CAGR of 13.8% during the Forecast Period: Grand View Research Inc.

San Francisco,17 October 2018: According to a report by Grand View Research, Inc., global controlled release drug delivery market is anticipated to value USD 90.18 billion by 2025. Growing requirement for reduction in amount of drug dose and dosage frequency to achieve prolonged therapeutic effect is anticipated to propel demand for controlled release drug delivery system. These systems are likely to offer multiple benefits over conventional medication delivery methods such as fewer adverse gastrointestinal effects, uniform drug effect, and enhanced patient compliance.

Rising R&D investments to develop advanced drug delivery systems offering ease of medication administration can influence growth of market. Growing need for controlled release of medication dosage for geriatric and pediatric patients can spur market growth. Growing adoption of systems that can deliver medication at predetermined rate systematically or locally can augment growth of market during the forecast period (2014 to 2025).

The controlled release drug delivery market can be segregated on the basis of technology, release mechanism, application, and region. Based on technology, the market can be categorized into microencapsulation, wurster technique, implants, transdermal, targeted delivery, coacervation, and others. Targeted delivery segment dominated the market and accounted for largest market share in recent years. It can help delivering medication to target site and can prevent toxicity by keeping it away from other sites. In addition, it can bring uniform effect of medication and reduce fluctuation in circulating drug levels.

Access Research Report of Controlled Release Drug Delivery Market@ www.grandviewresearch.com/industry-analysis/controlled-release-drug-delivery-market

On the contrary, microencapsulation segment is likely to gain traction among consumers owing to rising demand among companies over traditional drug delivery methods. It can reduce toxicity and hence preferred among doctors for treatment of pediatric and geriatric patients.

Based on release mechanism, the market can be classified into feedback regulated drug delivery systems, polymer matrix based systems, activation-modulated drug delivery systems, micro reservoir partition controlled drug delivery systems, and chemically activated. In 2016, polymer matrix based systems segment dominated the market and accounted for largest market share owing to high demand. Ability to release controlled and spatial release of loaded therapeutics coupled with their rate dissolution can stimulate growth of segment.

Similarly, chemically controlled systems segment can witness significant growth over the forecast period. These systems can include hydrolysis activated systems, pH-activated systems, and enzyme-responsive solutions.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Based on application, the market can be divided into metered dose inhalers, injectable, transdermal and ocular patches, infusion pumps, oral controlled-drug delivery systems, and drug eluting stents. In 2016, oral systems segment dominated the market and accounted for largest market share attributed to frequent usage and availability. In addition, these systems can offer targeted delivery and hence preferred over conventional methods. Moreover, rising need for generic medication is likely to create demand for oral drug delivery systems to limit quantity of medicine used.

Similarly, metered dose inhalers segment can also witness growth owing to its ability to administer medication in controlled form using nanoparticles and polymeric materials. Controlled release of drug to treat pulmonary disease can reduce frequency of dosage by allowing medication to be delivered at desired site of action can surge demand for metered dose inhalers.

Moreover, drug-eluting stents can be used for treatment of several cardiac disorders.

Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East & Africa. In 2016, North America dominated the market and accounted for largest market share. Continual deployment of favorable government initiatives for development of controlled release drug delivery coupled with rising investments in R&D activities can fuel market growth. In addition, high prevalence of leading market players in the region can augment growth of market. Moreover, growing number of NDA and ANDA applications in the region coupled with rising use of controlled release drug delivery systems by pharmaceutical companies can stimulate market growth.

In Asia Pacific, the market is expected to witness significant growth at highest CAGR over the forecast period. Continual developments in pharmaceutical sector coupled with rising R&D investments by multinational companies can influence growth of market. In addition, liberal federal regulations and untapped market opportunities can fuel market growth.

Some of the leading companies offering controlled release drug delivery systems are Johnson and Johnson; Corium International, Inc.; Alkermes plc; Orbis Biosciences, Inc.; and Aradigm Corporation.

Access Press Release of Controlled Release Drug Delivery Market@ www.grandviewresearch.com/press-release/global-controlled-release-drug-delivery-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Aktuelle Nachrichten Gesundheit/Medizin Pressemitteilungen

Pharmacy Inventory Management Software Solutions and Cabinets Market is Estimated to Reach a Valuation of $7.16 Billion by 2025

San Francisco,17 October 2018: The global pharmacy inventory management software solutions and cabinets market size is expected to reach USD 7.16 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting an 8.6% CAGR during the forecast period. Increasing number of dispensed prescriptions, growing adoption of pharmacy automation systems, and rising incidence of medication errors are some of the key drivers for this market. Technological advancements in automated dispensing cabinets design are also expected to positively impact market growth in the coming years.

Rising number of retail, mail order, and long-term care (LTC) pharmacies propel demand for inventory management software and systems in order to dispense high volume of medications. Rising pressure by governments to minimize medication costs is further expected to drive demand for these software and cabinets, as they aid in reduction of excess inventory costs. Increasing demand for efficient workflow in hospitals and pharmacies is also contributing toward market growth.

Demand for automated dispensing cabinets is increasing in retail pharmacies owing to increasing workload on pharmacists, coupled with surging need for effective patient counselling. In addition, rising government initiatives towards improvement in healthcare infrastructure and growing healthcare expenditure in developing countries are positively influencing market growth.

Access Research Report of Pharmacy Inventory Management Software Solutions and Cabinets Market@ www.grandviewresearch.com/industry-analysis/pharmacy-inventory-management-software-solutions-cabinets-market

Further key findings from the report suggest:

  • Pharmacy inventory management systems/cabinets in retail pharmacies emerged as the leading segment in terms of revenue in 2017 owing to rising number of retail pharmacies and growing number of prescriptions
  • By mode of operation, decentralized systems/cabinets accounted for the largest revenue share in 2017 owing to rising incidence of medication errors and increasing number of dispensed prescriptions
  • In terms of geography, North America dominated the global market in 2017 in terms of revenue and Asia Pacific is expected to register the highest growth rate over the forecast period
  • Omnicell, Inc.; BD; Talyst, LLC; and ARxIUM are the major players operating in the market. This market is dominated by the presence of both multinational companies and small players.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global pharmacy inventory management software solutions and cabinets market on the basis of end use, mode of operation, and region:

Pharmacy Inventory Management Software Solutions and Cabinets End-use Outlook (Revenue, USD Million, 2014 – 2025)

  • Independent pharmacies
    • Software Solutions
    • Cabinets
  • Hospital pharmacies
    • Software Solutions
    • Cabinets
  • Long-term care centers
    • Software Solutions
    • Cabinets

Pharmacy Inventory Management Software Solutions and Cabinets Mode of Operation Outlook (Revenue, USD Million, 2014 – 2025)

  • Centralized systems
    • Software Solutions
    • Cabinets
  • Decentralized systems
    • Software Solutions
    • Cabinets

Pharmacy Inventory Management Software Solutions and Cabinets Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia-Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East Africa
    • South Africa

Access Press Release of Pharmacy Inventory Management Software Solutions and Cabinets Market@ www.grandviewresearch.com/press-release/global-pharmacy-inventory-management-software-solutions-cabinets-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Gesundheit/Medizin

3D Bioprinting Market to Witness Robust Expansion throughout the Forecast 2015-2025

Rapidly increasing usage of 3D bioprinting in drug testing and cosmetic surgery along with growing demand for the 3D bio-printed organs has been witnessed as trends fuelling the growth of 3D bioprinting market. Usage of 3D bioprinting is likely to increase across the pharmaceutical manufacturing units for the purpose of reducing the total cost of drug production. Growing cases of chronic illnesses resulting in tissue and organ implants together with surging life-span of the individuals is anticipated to drive the growth of 3D bioprinting market. In addition, lack of organ donors, technological advancement and integration of IT within healthcare industry and growing geriatric population are further stimulating the growth of 3D bioprinting market across the globe.

Spritam (levetiracetam) that was introduced by a specialty pharmaceutical firm named Aprecia Pharmaceutical gained FDA approval as the first drug with 3D bioprinting and is expected to witness increasing demand across the globe in the forthcoming years.

Request Sample Report @https://www.futuremarketinsights.com/reports/sample/rep-gb-808

Key players and manufacturers in 3D bioprinting market have been taking immense efforts in increasing R&D expenditure for developing better stability 3D bioprinting products with increased efficiency. For example, 3D bioprinting using graphene holds high level strength compared to plastic resulting in durable and comfortable prosthetics. Growing prevalence of cancer cases is anticipated to be the key factor attributing towards the increased usage of 3D bioprinting across the globe.

3D Bioprinting also known as additive manufacturing is used to make three dimensional solid objects from a digital file which is achieved by using additive processes.

3D Bioprinting technology developed from prototyping in various applications for development of actual usable parts and products. 3D bioprinting market facilitates the opportunities for prosthesis, dental implants, hearing aids, contact lenses, hips implant, custom made knee and etc. that are customized and personalized according to the individual, one of the advances of 3D printing is known as bio-printing or the ability to print living tissues.

3D printer use “bio-ink,” a blend of living cells, the bio-printer create a structure from these cells, layer by layer, to create human tissue. By the help of 3D bioprinting physicians can use patient-specific data to capture, modify and at last apply various physical solutions of all shapes and sizes to the patient, without such application or technology, personalized treatment to patient would be difficult, as patients will need unique parts that can be rapidly and simply manufactured. It’s also helps to reduce surgery cost, time, trauma and healing period which is beneficial for both patient and surgeon.

3D Bioprinting Market: Drivers and Restraints

Presently, global 3D healthcare printing market is driven by the advancement in technology, increase in the percentage of aging population as old age is considered as the high risk factor for the development of various disorders, improvement in the healthcare infrastructure, and increase in the investment in research and development sector.

Technological advances in this dynamic industry are ever ongoing applications of additive manufacturing in healthcare are expanding. However, lack of skilled professional act as a major barrier for 3D healthcare printing global market.

3D Bioprinting Market: Segmentation

3D bioprinting global market is segmented into following types:

Electron beam melting

Laser beam melting

Photo-polymerization

Stereo lithography

Digital light processing

Two-photon polymerization

Droplet disposition

Inkjet printing

Fused disposition modeling

Multi-phase jet solidification

3D Bioprinting Market: Overview

With rapid technological advancement and increase in the investment in R&D sector, the global 3D bioprinting market is expected to have a healthy growth rate in the forecast period (2015-2025).

3D bioprinting global market is expected to witness significant growth, owing to intervention of government for improving healthcare infrastructure and increasing investments in R&D sector. In addition, healthcare professionals increasingly explore 3D bioprinting because it reduces the risks associated with anesthesia during long surgeries and improves healthcare.

Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-808

3D Bioprinting Market: Region-wise Outlook

Depending on geographic region, global 3D bioprinting market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

North America is the leading market for 3D bioprinting whereas Europe is expected to capture the large market shares followed by Asia Pacific region where the market is expected to grow due to rapid technological innovations, huge investment on research and development in these regions, large consumer base, and high disposable income.

 

3D Bioprinting Market: Key Players

Some of the key participating global players in 3D bioprinting global market are Stratasys Ltd., 3D Systems, Inc., Materialise NV, Organovo Holdings Inc., SOLS Systems, Youbionic, The Pexion Group, Oceanz 3D printing & Additive Manufacturing, and others.

Gesundheit/Medizin

Bioinformatics Market, By Products and Services and Bioinformatics Platforms (2018) and Global forecast 2023

According to the new market research report Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) – Global Forecast to 2023, published by MarketsandMarkets™, The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 7.73 billion in 2018, at CAGR of 14.5%. Growing demand for nucleic acid and protein sequencing, initiatives from government and private organizations, growing applications of bioinformatics, and the increasing number of collaborations between companies and research institutes are the major factors driving the growth of the market.

Don’t miss out on business opportunities in Bioinformatics Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2A4lMfb

Early buyers will receive 10% customization on reports.

The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 7.73 billion in 2018, at CAGR of 14.5%. Growing demand for nucleic acid and protein sequencing and the rising applications of bioinformatics in drug discovery, clinical diagnostics, and personalized medicine are key factors supporting the growth of this market. On the other hand, a lack of well-defined standards and common formats for data integration may limit market growth to a certain extent.

In this report, the market has been classified based on product & service, applications, sectors, and region. Based on product and service, the bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services. In 2018, the knowledge management tools segment is expected to account for the largest share of the market. The bioinformatics platforms segment is projected to grow at the highest rate during the forecast period. This high growth is attributed to an increase in the use of bioinformatics platforms in drug discovery and development.

On the basis of applications, the global bioinformatics market is divided into genomics, chemoinformatics and drug design, proteomics, transcriptomics, and metabolomics. In 2018, the genomics segment is expected to account for the largest share of the global bioinformatics market due to the increasing applications of genomics in personalized and preventive medicine.

On the basis of sector, the global bioinformatics market is divided into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, and forensic biotechnology. In 2018, the medical biotechnology segment is expected to account for the largest share of the global bioinformatics market. The rising adoption of bioinformatics tools in pharma and clinical applications is driving market growth.

In 2018, North America is expected to account for the largest share of the bioinformatics market. The large share of North America is attributed to the continued funding from the government and private sectors for life sciences research.

Browse and in-depth TOC on “Bioinformatics Market

189 – Tables

27 – Figures

195 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html

One of the major factors restraining market growth is the lack of well-defined standards and common formats for data integration. Most of the research institutes have their own exclusive identifiers, indexing schemes, and data formats. As data models change frequently, the data integration process becomes difficult. This may limit the growth of the market to a certain extent.

Key players that provide bioinformatics products and services are Thermo Fisher Scientific (US), Illumina Inc (US), Agilent Technologies (US), QIAGEN (Netherlands), BGI (China), Wuxi NextCODE (China), Eurofins Scientific (Luxembourg), Waters Corporation (US), Sophia Genetics (Switzerland), Partek (US) and DNASTAR (US). These players focus on both organic and inorganic growth strategies such as product launches, partnerships, and agreements to maintain and enhance their market share in the bioinform

Request for Free Sample Report @ http://bit.ly/2yd2SSd

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/bioinformatics-market.asp

Visit Our Website: https://www.marketsandmarkets.com

Gesundheit/Medizin

Vaccine Adjuvants Market: Size, Share, Applications, Technology Trends, Challenges and Forecast by 2021

According to the new market research report Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category – Forecasts to 2021, published by MarketsandMarkets™, The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%. The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

Don’t miss out on business opportunities in Vaccine Adjuvants Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2QLzrxv

Early buyers will receive 10% customization on reports.

The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016 at a CAGR of 10.5% from 2016 to 2021. The major factors driving the growth of this market are high prevalence of infectious and zoonotic diseases, increasing focus on immunization programs by various government bodies, and growing focus on improved and long-lasting immunization against existing and emerging diseases.

The report segments this market into product type, route of administration, disease type, applications, and application categories. On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. Particulate adjuvants are expected to account for the largest share of the market. Adjuvant emulsions, on the other hand, are projected to grow at the highest CAGR from The global vaccine adjuvants market consists of human and veterinary adjuvants that are used to improve the efficacy of vaccines. This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on prevention of diseases. The high growth potential in emerging markets has opened an array of opportunities for the market. However, the high cost of adjuvant-based research and proven safety of adjuvants are hampering the growth of the global market.

The vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016 at a CAGR of 10.5%. This market is segmented based on product type, route of administration, disease type, applications, and application category.

On the basis of product type, the market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and other adjuvants. The particulate adjuvants segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. High prevalence of infectious diseases and increasing funding for adjuvant research will drive the growth of this market segment.

Based on route of administration, the vaccine adjuvants market includes oral route, subcutaneous route, intranasal route, intramuscular route, intradermal route, and other routes. The intramuscular segment is expected to account for the largest share of the global market in 2016. Rising geriatric population and vaccines for improved immunization are the key factors propelling the growth of this market.

Based on disease type, the vaccine adjuvants market comprises of infectious diseases, cancer, and other diseases. The infectious diseases segment is expected to account for the largest share of the global market in 2016. High prevalence of infectious diseases and cancer is expected to drive market growth in the coming years.

Browse and in-depth TOC on “Vaccine Adjuvants Market

90 – Tables

42 – Figures

156 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html

Based on geography, the global vaccine adjuvants market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is expected to witness the highest CAGR, with the growth in this market centered at China and India. Rising prevalence of infectious diseases, increasing government investments for vaccine research and development, rising number of conferences and symposiums, and high growth in the Indian biotechnology sector are the major factors driving the market in the Asian region.

The major players in the vaccine adjuvants market are Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

Request for Free Sample Report @ http://bit.ly/2IOCClb

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/vaccine-adjuvants-market.asp

Visit Our Website: https://www.marketsandmarkets.com